Eli Lilly's head of obesity talks weight-loss innovations for 2025 — from an Ozempic-like pill to a triple-threat shot
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
Arizona Daily Star1d
Ozempic vs. Semaglutide: 10 Weight Loss Medications Compared for 2025
Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...
Weight loss jab prescriptions need tougher regulations, say pharmacists
Online sales of weight-loss drugs, including WeGovy and Mounjaro, have been criticised since they were introduced. The World ...
Diabetes.co.uk5d
Weight loss jabs associated with good cognition but poor kidney function
A new study led by Washington University School of Medicine has demonstrated that popular weight loss drugs can improve a ...
FDA approves Novo Nordisk's diabetes drug Ozempic for chronic kidney disease, expanding use in U.S.
Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...
i3dOpinion
It's time for a hybrid NHS-private health model – but only for weight loss drugs
There are precedents for a hybrid NHS-private model of healthcare. Ten years ago, a new drug treatment arrived that could ...
Everything you need to know about weight loss jabs such as Wegovy as chemists demand clampdown
Millions of Brits are now eligible for the appetite-suppressing jabs which can come with unpleasant side effects - but NHS rationing means only a tiny fraction will be prescribed them ...
Hosted on MSN6d
Ozempic: How it’s Transforming Diabetes Management and Weight Loss
The following content is for informational purposes only. This article is not intended to be a substitute for profession ...
Medscape5d
A Guide for Discussing GLP-1s as Obesity Treatments
The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...